Funding and Structured Finance

Alantra CPA is positioned as the best in class, independent advisor in Structured Finance and Securitised Products and Solutions (“ACPSS”) to banks, non-bank lenders and corporates in Europe. Our approach builds  on a deep understanding of the underlying assets to be securitised (or funded) and market leading analytical capabilities gained as a leading credit portfolio advisor spanning the full range of assets from distressed loans to  performing corporate receivables or real estate owned assets.  Combined with the team’s extensive knowledge of the structured credit, Asset Backed Securities (ABS), public and private debt capital markets, we provide independent and unconflicted advice as well as placement capabilities across the credit spectrum.

The ACPSS team of more than 15 senior professionals and c. 50 specialist credit modellers dedicated to advising in Securitisation and Structured Finance transactions and leverages the CPA global footprint to provide its clients with a unique blend of “best in class” know how in structuring and placement with, local knowledge from its in country credit experts. Since joining Alantra, the Alantra CPA team have advised on completed securitisation transactions with c. €15bn of GBV in the last 2 years, including some of the first and largest transactions ever executed in Greece, Cyprus and Spain. The team has also demonstrated its ability to optimise funding and capital for banks and non-bank lenders across Europe, sourcing and completing successful financing for loan originators across a diverse range of asset classes, including asset finance (Project Juniper) and development loans (Project Landmark).Our ACPSS team leverage the distribution network and global investor base of Alantra CPA and Alantra Group. The solutions encompass, inter alia:

• Bespoke senior and mezzanine financing facilities
• Sourcing commitments of junior, equity and growth capital
• Arranging forward flow transactions
• Structuring, rated and unrated, ABS transactions for deleveraging, capital and funding purposes
• Significant Risk Transfer (SRT) transactions to reduce regulatory capital requirements
• Pricing, valuation and options analysis in relation to the above